• Mon. Sep 15th, 2025

CoronaVirus

  • Home
  • Panthera becomes the world’s first clinical trial site to administer Valneva’s inactivated COVID-19 vaccine (VLA2001) to volunteers in phase 3 study

Panthera becomes the world’s first clinical trial site to administer Valneva’s inactivated COVID-19 vaccine (VLA2001) to volunteers in phase 3 study

Panthera has started vaccinating volunteers in Valneva’s double-blind, phase three, COVID prevention trial. The trial will compare Valneva’s inactivated vaccine, VLA2001, with AstraZeneca’s conditionally approved vaccine Vaxzeria. Unlike earlier COVID-19…

Commuters tripled COVID-19 cases in UK before lockdown

Commuters moving between different counties increased COVID cases in the UK significantly before lockdown was imposed, according to new research by Vienna University of Economics and Business (WU). The study,…

Driver Bubble™ and FixiCover add ‘Mercedes E-class’ to the existing list of TFL approved vehicle protection screens

Amsterdam, The Netherlands, March 31st 2021 – The global market leader in vehicle partitions screens, Driver Bubble™, announced today that it has received approval from Transport for London, for the…

LEGATUM INSTITUTE PUBLISHES REVIEW OF SCHOOLS RE-OPENING DECISION

A new report by the Legatum Institute reviews the assumptions associated with the decision to re-open schools in England on 8th March, and finds them to have been reliable. The…

Bunny sales hop 173% during lockdown in London

BUNNIES HOP TO THE TOP AS SALES SOAR 173% IN LONDON Increase in pet rabbits over lockdown could mean hundreds are left homeless this Easter As the British public approaches…